Task: Answer the multiple choice question.
Query: Which drug exhibits a 30.065% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCOC(=O)c1[nH]c(C)c(C(=O)NCCN2CCOCC2)c1C
b: Cc1ccccc1C(=O)Nc1ccccc1NC(=O)c1ccccc1C
c: O=C(O)CCn1cc(/C=C2\NC(=S)N(c3ccccc3)C2=O)c(-c2ccc(Br)cc2)n1
Answer: c. O=C(O)CCn1cc(/C=C2\NC(=S)N(c3ccccc3)C2=O)c(-c2ccc(Br)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)CCn1cc(/C=C2\NC(=S)N(c3ccccc3)C2=O)c(-c2ccc(Br)cc2)n1
O=C(O)CCn1cc(/C=C2\NC(=S)N(c3ccccc3)C2=O)c(-c2ccc(Br)cc2)n1
3-[3-(4-bromophenyl)-4-[(Z)-(5-oxo-1-phenyl-2-sulfanylideneimidazolidin-4-ylidene)methyl]pyrazol-1-yl]propanoic acid